These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8007014)

  • 1. An added dimension: will three-dimensional cultures improve our understanding of drug resistance?
    Steeg PS; Alley MC; Grever MR
    J Natl Cancer Inst; 1994 Jul; 86(13):953-5. PubMed ID: 8007014
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor hypoxia, drug resistance, and metastases.
    Brown JM
    J Natl Cancer Inst; 1990 Mar; 82(5):338-9. PubMed ID: 2406450
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemosensitizers to overcome and prevent multidrug resistance?
    Germann UA; Harding MW
    J Natl Cancer Inst; 1995 Nov; 87(21):1573-5. PubMed ID: 7563195
    [No Abstract]   [Full Text] [Related]  

  • 4. [Multidrug resistance].
    Donenko FV; Sitdikova SM; Moroz LV
    Vopr Onkol; 1991; 37(7-8):780-8. PubMed ID: 1842629
    [No Abstract]   [Full Text] [Related]  

  • 5. Clonogenicity and growth of experimental tumors in relation to developing resistance and therapeutic failure.
    Griswold DP; Corbett TH; Schabel FM
    Cancer Treat Rep; 1981; 65 Suppl 2():51-4. PubMed ID: 7346146
    [No Abstract]   [Full Text] [Related]  

  • 6. Mathematical models of drug resistance and chemotherapy effects.
    Goldie JH
    Cancer Treat Res; 1989; 48():13-26. PubMed ID: 2577135
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of the effectiveness of antitumor actions by the dynamics of tumor growth inhibition].
    Konradov AA; Karakulov RK
    Izv Akad Nauk SSSR Biol; 1986; (1):115-21. PubMed ID: 3950189
    [No Abstract]   [Full Text] [Related]  

  • 8. Physiologic mechanisms of therapeutic resistance. Blood flow and hypoxia.
    Teicher BA
    Hematol Oncol Clin North Am; 1995 Apr; 9(2):475-506. PubMed ID: 7642474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance modulation in the laboratory and the clinic.
    Dalton WS
    Semin Oncol; 1993 Feb; 20(1):64-9. PubMed ID: 8475411
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple drug resistance in cancer therapy.
    Schneider E; Cowan KH
    Med J Aust; 1994 Mar; 160(6):371-3. PubMed ID: 7907772
    [No Abstract]   [Full Text] [Related]  

  • 11. Multidrug resistance.
    Moscow JA; Cowan KH
    J Natl Cancer Inst; 1988 Mar; 80(1):14-20. PubMed ID: 2892943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New approaches to antitumor therapy: the use of preparations acting on processes regulated by epidermal and/or alpha-transforming growth factors].
    Kushlinskiĭ NE; Gershteĭn ES
    Eksp Klin Farmakol; 1996; 59(1):74-80. PubMed ID: 8704642
    [No Abstract]   [Full Text] [Related]  

  • 13. [Reversal of drug resistance and prediction of the response to cytostatics. Experimental drug therapy for tumors has clinical potential].
    Larsson R; Nygren P; Bergh J
    Lakartidningen; 1991 Dec; 88(51-52):4441-4. PubMed ID: 1774991
    [No Abstract]   [Full Text] [Related]  

  • 14. [Oncobiogram and its significance in the choice and efficacy of cytostatic therapy].
    Savran VR
    Vopr Onkol; 1983; 29(3):106-13. PubMed ID: 6340347
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of multi-drug resistance in genito-urinary tumors].
    Theyer G; Hamilton G
    Prog Urol; 1993 Jun; 3(3):385-92; discussion 392-3. PubMed ID: 8103698
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chalones and tumor growth].
    Okulov VB
    Vopr Onkol; 1981; 27(4):101-14. PubMed ID: 6453470
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug resistance and implication for therapy].
    Tsuruo T
    Rinsho Ketsueki; 1989 Aug; 30(8):1128-32. PubMed ID: 2574754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future potential of adjuvant and neoadjuvant therapy.
    Yarbro JW
    Semin Oncol; 1991 Dec; 18(6):613-9. PubMed ID: 1775978
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cell resistence to harmful factors].
    Montsevichiute-Eringene
    Patol Fiziol Eksp Ter; 1972; 16(6):83-9. PubMed ID: 4578709
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunological aspects of resistance to antineoplastic chemotherapy].
    D'Alessandro N
    Clin Ter; 1991 Jul; 138(1):37-44. PubMed ID: 1834399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.